← Back to directory

José‐Ángel Hernández‐Rivas

Researcher Next ID · RN-043480

Researcher · Biochemistry, Genetics and Molecular Biology

Universidad Complutense de Madrid

Madrid, Mexico

Accepting doctoral researchersFunding unknown
Works count
560
Citation count
9,142
H-index
51
i10-index
164

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Chronic Lymphocytic Leukemia Research
Lymphoma Diagnosis and Treatment
Multiple Myeloma Research and Treatments
Protein Degradation and Inhibitors
Chemokine receptors and signaling

Publications

  • Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma

    New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2201817

  • COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

    Leukemia · 2021 · https://doi.org/10.1038/s41375-021-01450-8

  • Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study

    Journal of Hematology & Oncology · 2020 · 10.1186/s13045-020-00970-7

  • COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

    Leukemia · 2020 · https://doi.org/10.1038/s41375-020-0959-x

  • Outcomes of COVID-19 in patients with CLL: a multicenter international experience

    Blood · 2020 · https://doi.org/10.1182/blood.2020006965

  • Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis

    Haematologica · 2018 · 10.3324/haematol.2018.205229

  • Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

    American Journal of Hematology · 2014 · 10.1002/ajh.23900

  • Genome Sequence of Azotobacter vinelandii , an Obligate Aerobe Specialized To Support Diverse Anaerobic Metabolic Processes

    Journal of Bacteriology · 2009 · 10.1128/jb.00504-09

  • Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

    Blood · 2008 · https://doi.org/10.1182/blood-2008-05-159624

  • Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome

    Blood · 2002 · 10.1182/blood.v99.5.1853

  • Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases

    British Journal of Haematology · 2001 · https://doi.org/10.1046/j.1365-2141.2001.03144.x

Current projects

    No projects listed.